Gan & Lee Pharmaceuticals. (SHA:603087)
65.97
+0.17 (0.26%)
Feb 27, 2026, 3:00 PM CST
SHA:603087 Market Cap
SHA:603087 has a market cap or net worth of 39.27 billion as of February 27, 2026. Its market cap has increased by 49.02% in one year.
Market Cap
39.27B
Enterprise Value
36.10B
Revenue
3.85B
Ranking
n/a
PE Ratio
41.92
Stock Price
65.97
Market Cap Chart
Since June 29, 2020, SHA:603087's market cap has increased from 36.57B to 39.27B, an increase of 7.36%. That is a compound annual growth rate of 1.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 26, 2026 | 39.16B | -3.33% |
| Dec 31, 2025 | 40.52B | 53.87% |
| Dec 31, 2024 | 26.33B | -15.24% |
| Dec 29, 2023 | 31.07B | 68.57% |
| Dec 30, 2022 | 18.43B | -53.34% |
| Dec 31, 2021 | 39.50B | -46.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Imeik Technology Development | 43.91B |
| Intco Medical Technology | 27.06B |
| iRay Group | 25.33B |
| Zhende Medical | 23.86B |
| Winner Medical | 20.67B |
| Andon Health | 18.86B |
| Shenyang Xingqi Pharmaceutical | 17.35B |
| Micro-Tech (Nanjing) Co.,Ltd | 15.35B |